| A new taxonomy for describing and defining adherence to medications B Vrijens, S De Geest, DA Hughes, K Przemyslaw, J Demonceau, ... British journal of clinical pharmacology 73 (5), 691-705, 2012 | 2442 | 2012 |
| Rare disease terminology and definitions—a systematic global review: report of the ISPOR rare disease special interest group T Richter, S Nestler-Parr, R Babela, ZM Khan, T Tesoro, E Molsen, ... Value in health 18 (6), 906-914, 2015 | 572 | 2015 |
| Is exercise effective in promoting mental well-being in older age? A systematic review G Windle, D Hughes, P Linck, I Russell, B Woods Aging & mental health 14 (6), 652-669, 2010 | 464 | 2010 |
| Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis AV Ramanan, AD Dick, AP Jones, A McKay, PR Williamson, ... New England Journal of Medicine 376 (17), 1637-1646, 2017 | 453 | 2017 |
| Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic … J Demonceau, T Ruppar, P Kristanto, DA Hughes, E Fargher, P Kardas, ... Drugs 73, 545-562, 2013 | 415 | 2013 |
| ESPACOMP medication adherence reporting guideline (EMERGE) S De Geest, LL Zullig, J Dunbar-Jacob, R Helmy, DA Hughes, IB Wilson, ... Annals of internal medicine 169 (1), 30-35, 2018 | 389 | 2018 |
| Cost-effectiveness analysis of HLA B* 5701 genotyping in preventing abacavir hypersensitivity DA Hughes, FJ Vilar, CC Ward, A Alfirevic, BK Park, M Pirmohamed Pharmacogenetics and Genomics 14 (6), 335-342, 2004 | 355 | 2004 |
| Drugs for exceptionally rare diseases: do they deserve special status for funding? DA Hughes, B Tunnage, ST Yeo Qjm 98 (11), 829-836, 2005 | 287 | 2005 |
| Non-compliance with antibiotic therapy for acute community infections: a global survey JC Pechère, D Hughes, P Kardas, G Cornaglia International journal of antimicrobial agents 29 (3), 245-253, 2007 | 273 | 2007 |
| Societal views on NICE, cancer drugs fund and value‐based pricing criteria for prioritising medicines: A cross‐sectional survey of 4118 adults in Great Britain WG Linley, DA Hughes Health economics 22 (8), 948-964, 2013 | 261 | 2013 |
| Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysis RT Edwards, A Céilleachair, T Bywater, DA Hughes, J Hutchings Bmj 334 (7595), 682, 2007 | 254 | 2007 |
| The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature DA Hughes, A Bagust, A Haycox, T Walley Health economics 10 (7), 601-615, 2001 | 253 | 2001 |
| Predicting adherence to medications using health psychology theories: a systematic review of 20 years of empirical research EAF Holmes, DA Hughes, VL Morrison Value in Health 17 (8), 863-876, 2014 | 250 | 2014 |
| Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and … FH Gwadry-Sridhar, E Manias, L Lal, M Salas, DA Hughes, ... Value in health 16 (5), 863-871, 2013 | 235 | 2013 |
| Nurse‐led vs. conventional physician‐led follow‐up for patients with cancer: systematic review R Lewis, RD Neal, NH Williams, B France, C Wilkinson, M Hendry, ... Journal of advanced nursing 65 (4), 706-723, 2009 | 230 | 2009 |
| The ROAM/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial MD Jenkinson, M Javadpour, BJ Haylock, B Young, H Gillard, J Vinten, ... Trials 16, 1-8, 2015 | 228 | 2015 |
| Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses J Pink, S Lane, M Pirmohamed, DA Hughes Bmj 343, 2011 | 227 | 2011 |
| Generic and therapeutic substitutions in the UK: are they a good thing? MG Duerden, DA Hughes British journal of clinical pharmacology 70 (3), 335-341, 2010 | 201 | 2010 |
| Follow-up of cancer in primary care versus secondary care: systematic review RA Lewis, RD Neal, NH Williams, B France, M Hendry, D Russell, ... British Journal of General Practice 59 (564), e234-e247, 2009 | 184 | 2009 |
| The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non … A Marson, G Burnside, R Appleton, D Smith, JP Leach, G Sills, ... The Lancet 397 (10282), 1375-1386, 2021 | 183 | 2021 |
Emily Fargher HolmesResearch Fellow, Bangor UniversityПодтвержден адрес электронной почты в домене bangor.ac.uk
